1. Home
  2. AFMD vs TYGO Comparison

AFMD vs TYGO Comparison

Compare AFMD & TYGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFMD
  • TYGO
  • Stock Information
  • Founded
  • AFMD 2000
  • TYGO 2007
  • Country
  • AFMD Germany
  • TYGO United States
  • Employees
  • AFMD N/A
  • TYGO N/A
  • Industry
  • AFMD Biotechnology: Pharmaceutical Preparations
  • TYGO Semiconductors
  • Sector
  • AFMD Health Care
  • TYGO Technology
  • Exchange
  • AFMD Nasdaq
  • TYGO Nasdaq
  • Market Cap
  • AFMD 45.6M
  • TYGO 53.5M
  • IPO Year
  • AFMD 2014
  • TYGO N/A
  • Fundamental
  • Price
  • AFMD $1.26
  • TYGO $0.88
  • Analyst Decision
  • AFMD Strong Buy
  • TYGO Buy
  • Analyst Count
  • AFMD 5
  • TYGO 3
  • Target Price
  • AFMD $13.50
  • TYGO $3.00
  • AVG Volume (30 Days)
  • AFMD 502.9K
  • TYGO 31.8K
  • Earning Date
  • AFMD 11-14-2024
  • TYGO 02-11-2025
  • Dividend Yield
  • AFMD N/A
  • TYGO N/A
  • EPS Growth
  • AFMD N/A
  • TYGO N/A
  • EPS
  • AFMD N/A
  • TYGO N/A
  • Revenue
  • AFMD $6,287,085.00
  • TYGO $45,985,000.00
  • Revenue This Year
  • AFMD N/A
  • TYGO N/A
  • Revenue Next Year
  • AFMD $28.44
  • TYGO $57.24
  • P/E Ratio
  • AFMD N/A
  • TYGO N/A
  • Revenue Growth
  • AFMD N/A
  • TYGO N/A
  • 52 Week Low
  • AFMD $1.19
  • TYGO $0.78
  • 52 Week High
  • AFMD $8.95
  • TYGO $2.19
  • Technical
  • Relative Strength Index (RSI)
  • AFMD 14.41
  • TYGO 43.45
  • Support Level
  • AFMD $2.02
  • TYGO $0.86
  • Resistance Level
  • AFMD $2.21
  • TYGO $0.99
  • Average True Range (ATR)
  • AFMD 0.26
  • TYGO 0.07
  • MACD
  • AFMD -0.09
  • TYGO 0.01
  • Stochastic Oscillator
  • AFMD 4.09
  • TYGO 50.23

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

About TYGO Tigo Energy Inc.

Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems.

Share on Social Networks: